Borsi, E; Perrone, G; Terragna, C; Martello, M; Mancini, M; Leo, E; Zamagni, E; Tacchetti, P; Brioli, A; Pantani, L; Zannetti, B; Martinelli, G; Cavo, M, SIRT regulates the molecular interaction between c-MYC and HIF-1 alpha in multiple myeloma, in: CANCER RESEARCH, 2013, pp. 3415 - 3415 (atti di: 104th Annual Meeting of the American-Association-for-Cancer-Research (AACR), Washington, DC, APR 06-10, 2013) [atti di convegno-abstract]
Nanni C; Zamagni E; Celli M; Caroli P; Ambrosini V; Tacchetti P; Brioli A; Zannetti B; Pezzi A; Pantani L; Perrone G; Zompatori M; Cavo M; Colletti PM; Rubello D; Fanti S., The Value of 18F-FDG PET/CT after Autologous Stem Cell Transplantation (ASCT) in Patients Affected by Multiple Myeloma (MM): Experience With 77 Patients, «CLINICAL NUCLEAR MEDICINE», 2013, 38, pp. e74 - e79 [articolo]
Cavo M; Pantani L; Petrucci MT; Patriarca F; Zamagni E; Donnarumma D; Crippa C; Boccadoro M; Perrone G; Falcone A; Nozzoli C; Zambello R; Masini L; Furlan A; Brioli A; Derudas D; Ballanti S; Dessanti ML; De Stefano V; Carella AM; Marcatti M; Nozza A; Ferrara F; Callea V; Califano C; Pezzi A; Baraldi A; Grasso M; Musto P; Palumbo A., Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy following autologous hematopoietic stem-cell transplantation in patients with newly diagnosed multiple myeloma., «BLOOD», 2012, 120, pp. 9 - 19 [articolo]
P. Spinnato; A. Bazzocchi; A. Brioli; C. Nanni; E. Zamagni; U. Albisinni; M. Cavo; S. Fanti; G. Battista; E. Salizzoni, Contrast enhanced MRI and (18)F-FDG PET-CT in the assessment of multiple myeloma: a comparison of results in different phases of the disease, «EUROPEAN JOURNAL OF RADIOLOGY», 2012, 81, pp. 4013 - 4018 [articolo]
Alessandro Gozzetti; Alfonso Cerase; Flavia Lotti; Davide Rossi; Antonio Palumbo; Maria Teresa Petrucci; Francesca Patriarca; Chiara Nozzoli; Michele Cavo; Massimo Offidani; Michele Floridia; Salvatore Berretta; Roberto Vallone; Pellegrino Musto; Francesco Lauria; and for the GIMEMA (Gruppo Italiano Malattie Ematologiche dell'Adulto) Myeloma Working Party; additional authors who participated to the study: Elena Marchini; Alberto Fabbri; Stefania Oliva; Elena Zamagni; Fabiana Gentilini; Stelvio Ballanti; Giuseppe Mele; Monica Galli; Maria Teresa Pirrotta; Francesco Di Raimondo, Extramedullary intracranial localization of multiple myeloma and treatment with novel agents: a retrospective survey of 50 patients, «CANCER», 2012, 118, pp. 1574 - 1584 [articolo]
Terragna, C; Martello, M; Martinelli, G; Durante, S; Pantani, L; Zamagni, E; Tacchetti, P; Brioli, A; Perrone, G; Zannetti, Ba; Borsi, E; Biasco, G; Baccarani, M; Cavo, M., Gene expression analysis of newly diagnosed Multiple Myeloma (MM) patients carrying amplified MDM4 and/or deleted p5, in: Suppl. 1, Chicago, «CANCER RESEARCH», 2012, 72, pp. 1873 - 1873 (atti di: AACR 2012 Annual Meeting, Chicago, 30 March - 04 April 2012) [atti di convegno-abstract]
Terragna C; Martello M; Pantani L; Patriarca F; Zamagni E; Galli M; Tacchetti P; Petrucci MT; Crippa C; Bringhen S; Brioli A; Offidani M; Perrone G; Zannetti BA; Borsi E; Testoni N; Marzocchi G; Baccarani M; Martinelli G; Cavo M., High CNA level and over-expression of genes involved in response mechanisms to genotoxic stress characterize newly diagnosed Multiple Myeloma (MM) patients carrying amplified MDM4 and/or deleted TP53, in: s1, «HAEMATOLOGICA», 2012, 97, pp. 240 - 240 (atti di: 17th Congress of the European Hematology Association, Amsterdam, The Netherlands, June 14 – 17, 2012) [atti di convegno-abstract]
Brioli A;Zamagni E;Pasquali S;Tosi P;Tacchetti P;Perrone G;Pantani L;Petrucci A;Zannetti BA;Baccarani M;Cavo M, Long-term follow-up after autologous stem cell transplantation for light- and heavy-chain deposition disease., «BONE MARROW TRANSPLANTATION», 2012, 47, pp. 1248 - 1249 [articolo]
Zamagni E; Petrucci A; Tosi P; Tacchetti P; Perrone G; Brioli A; Pantani L; Zannetti B; Terragna C; Baccarani M; Cavo M., Long-term results of thalidomide and dexamethasone (thal-dex) as therapy of first relapse in multiple myeloma., «ANNALS OF HEMATOLOGY», 2012, 91, pp. 419 - 426 [articolo]
Mancini; Elisa Leo; Elena Zamagni; Paola Tacchetti; Annamaria Brioli; Lucia Pantani; Beatrice Anna Zannetti; Giovanni Martinelli; Michele Cavo, SIRT Regulates the Molecular Interaction Between c-MYC and HIF-1α in Multiple Myeloma, in: Blood, «BLOOD», 2012, 120(21), pp. 574 - 574 (atti di: 54th ASH Annual Meeting, Atlanta, GA, December 8 – 11, 2012) [atti di convegno-abstract]
Elena Zamagni;Michele Cavo, The role of imaging techniques in the management of multiple myeloma, «BRITISH JOURNAL OF HAEMATOLOGY», 2012, 159, pp. 499 - 513 [articolo]
Palumbo A.; Cavo M.; Bringhen S.; Zamagni E.; Romano A.; Patriarca F.; Rossi D.; Gentilini F.; Crippa C.; Galli M.; Nozzoli C.; Ria R.; Marasca R.; Montefusco V.; Baldini L.; Elice F.; Callea V.; Pulini S.; Carella A.M.; Zambello R.; Benevolo G.; Magarotto V.; Tacchetti P.; Pescosta N.; Cellini C.; Polloni C.; Evangelista A.; Caravita T.; Morabito F.; Offidani M.; Tosi P.; Boccadoro M., Aspirin, warfarin, or enoxaparin thromboprophylaxis in patients with multiple myeloma treated with thalidomide: a phase III, open-label, randomized trial., «JOURNAL OF CLINICAL ONCOLOGY», 2011, 29, pp. 986 - 993 [articolo]
PERRONE G; BORSI E; TERRAGNA C; DURANTE S; MARTELLO M; ALUIGI M; MANCINI M; ZAMAGNI E; TACCHETTI P; BRIOLI A; PANTANI L; ZANNETTI BA; MARTINELLI G; SANTUCCI MA; BACCARANI M; CAVO M, HIF 1 Alpha: A Suitable Target for Multiple Myeloma, in: Blood, «BLOOD», 2011, 118, pp. 2901 - 2901 (atti di: 2011 ASH Annual Meeting, San Diego, CA, 9 – 12 December) [atti di convegno-abstract]
TERRAGNA C; MARTELLO M; DURANTE S; PANTANI L; ZAMAGNI E; TACCHETTI P; BRIOLI A; PERRONE G; ZANNETTI BA; BORSI E; BACCARANI M; MARTINELLI G; CAVO M, High Number of Copy Number Alterations and Over-Expression of Genes Involved in the Response Mechanisms to Genotoxic Stress Both Characterize Newly Diagnosed Multiple Myeloma (MM) Patients Carrying Amplified MDM4 and/or Deleted p53, in: Blood, «BLOOD», 2011, 118, pp. 3935 - 3935 (atti di: 2011 ASH Annual Meeting, San Diego, CA, 9 – 12 December) [atti di convegno-abstract]
Zamagni E.; Brioli A.; Tacchetti P.; Zannetti B.; Pantani L.; Cavo M., Multiple myeloma, venous thromboembolism, and treatment-related risk of thrombosis., «SEMINARS IN THROMBOSIS AND HEMOSTASIS», 2011, 37, pp. 209 - 219 [articolo]
